Agenda: Ontario Steering Committee for Cancer Drugs (OSCCD)

Agenda: Ontario Steering Committee for Cancer Drugs (OSCCD)

Agenda: Ontario Steering Committee for Cancer Drugs
(OSCCD)
Date: November 25, 2013
Time: 12:00-3:00pm
Time
Topic
12:00-12:20
Welcome and Opening Remarks
12:20-12:25
Introductions of Members and Staff
12:25-12:30
Session objectives
Declaration of Conflicts of Interest
12:30-1:15
Quadramet: Drug Submission Review
1:15-1:30
BREAK
1:30-2:25
Anti-emetics: Recommendations Report Review
2:25-2:55
Perspectives from Committee to Evaluate Drugs (CED) & pan-Canadian Oncology
Drug Review (pCODR)
2:55-3:00
Closing remarks
Member Attendees
Dr. Craig Earle (Chair), Dr. Peter Anglin, Dr. Parneet Cheema, Dr. Matthew Cheung, Dr.
Peter Ellis, Dr. Hal Hirte, Dr. Christopher Longo, Dr. James Perry, Dr. Zahava RosenbergYunger, Dr. Srikala Sridhar, Laura Wilcock
Staff Attendees
Charlotte Bailey, Jaclyn Beca, Amanda Chan, Scott Gavura, Tracy Hicks, Dr. Jeffrey Hoch,
Dr. Leonard Kaizer, Karina Lee, Richard Lin, Diane McArthur, Lisa Milgram, Rohini Naipaul,
Christine Seager, Dr. Padraig Warde, Lyndee Yeung
Guests
Dr. Allan Grill, Dr. Thomas McGowan, Debbie Milliken, Erin Rae, Dr. Kathy Vu
Regrets
Members: Dr. Kelvin Chan
Staff: Brent Fraser, Glenn McAuley
Page 1 of 1